Showing results (561-570 of 1,957) with videos related to
Sort By:
Pageof 196
Journal of Psychoactive Drugs|August 20, 2003
The Clinical Opiate Withdrawal Scale (COWS)Donald R Wesson, Walter LingJournal of Psychoactive Drugs|June 27, 2003
Evidence-based prevention: characteristics, impact, and future directionMary Ann PentzJournal of Psychoactive Drugs|June 27, 2003
Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive peopleFrank H Galvan, M Audrey Burnam, Eric G BingJournal of Psychoactive Drugs|June 27, 2003
Effects of gender and diagnosis on addiction history, treatment utilization, and psychosocial functioning among a dually-diagnosed sample in drug treatmentChristine E GrellaJournal of Psychoactive Drugs|July 1, 1988
Pharmacological adjuncts in the treatment of opioid and cocaine addictsP Herridge, M S GoldJournal of Psychoactive Drugs|February 9, 2019
Barriers to Buprenorphine Expansion in Ohio: A Time-Elapsed Qualitative StudyTodd Molfenter, Maureen Fitzgerald, Nora Jacobson, et al.Journal of Psychoactive Drugs|February 12, 2019
Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An 18F-FDG PET/CT Case StudyLorenzo Moccia, Anna Tofani, Marianna Mazza, et al.Journal of Psychoactive Drugs|February 7, 2020
Uses, Effects and Toxicity of Synthetic Cannabinoids from the Perspective of People with Lived ExperiencesSulaf Assi, Danielle Marshall, Francesco Saverio Bersani, et al.Journal of Psychoactive Drugs|November 23, 2020
Characterizing Trends in Synthetic Cannabinoid Receptor Agonist Use from Patient Clinical Evaluations during Medical Toxicology ConsultationCollin Tebo, Maryann Mazer-Amirshahi, Paul Wax, et al.Journal of Psychoactive Drugs|November 23, 2020
Cognitive Impairment among People Who Use Heroin and Fentanyl: Findings from the Miami Adult Studies on HIV (MASH) CohortJavier A Tamargo, Adriana Campa, Sabrina S Martinez, et al.Pageof 196